Search

Your search keyword '"Arai Masaru"' showing total 7 results
Start Over Author "Arai Masaru" Journal heart and vessels
7 results on '"Arai Masaru"'

1. Trends in antithrombotic therapy and clinical outcomes for percutaneous coronary intervention in Japan following the 2020 JCS guideline focused update: findings from the SAKURA PCI2 Antithrombotic Registry

Author

Arai, Riku, Murata, Nobuhiro, Kojima, Keisuke, Matsumoto, Michiaki, Matsumoto, Naoya, Morikawa, Tomoyuki, Atsumi, Wataru, Tachibana, Eizo, Haruta, Hironori, Kogo, Takaaki, Ebuchi, Yasunari, Nomoto, Kazumiki, Arai, Masaru, Arima, Ken, Mineki, Takashi, Koyama, Yutaka, Oiwa, Koji, and Okumura, Yasuo

Published
2024
Full Text
View/download PDF

2. Impact of the COVID-19 pandemic on the hospitalizations, time course, presenting symptoms, and mid-term outcomes in patients with myocardial infarctions in a Japanese multi-center registry

Author

Arai, Riku, Nobuhiro, Murata, Kojima, Keisuke, Iida, Korehito, Kitano, Daisuke, Fukamachi, Daisuke, Watanabe, Yoji, Matsumoto, Michiaki, Matsumoto, Naoya, Hirata, Shu, Nomoto, Kazumiki, Sasa, Yusuke, Tachibana, Eizo, Arai, Masaru, Arima, Ken, Haruta, Hironori, and Okumura, Yasuo

Published
2023
Full Text
View/download PDF

4. Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry

Author

Usuda, Keisuke, Kato, Takeshi, Tsuda, Toyonobu, Tada, Hayato, Niwa, Satoru, Usui, Soichiro, Sakata, Kenji, Hayashi, Kenshi, Furusho, Hiroshi, Kawashiri, Masaaki, Takamura, Masayuki, Otsuka, Takayuki, Suzuki, Shinya, Hirata, Akio, Murakami, Masato, Takami, Mitsuru, Kimura, Masaomi, Fukaya, Hidehira, Nakahara, Shiro, Shimizu, Wataru, Iwasaki, Yu-ki, Hayashi, Hiroshi, Harada, Tomoo, Nakajima, Ikutaro, Okumura, Ken, Koyama, Junjiroh, Tokuda, Michifumi, Yamane, Teiichi, Momiyama, Yukihiko, Tanimoto, Kojiro, Soejima, Kyoko, Nonoguchi, Noriko, Ejima, Koichiro, Hagiwara, Nobuhisa, Harada, Masahide, Sonoda, Kazumasa, Inoue, Masaru, Kumagai, Koji, Hayashi, Hidemori, Satomi, Kazuhiro, Yazaki, Yoshinao, Watari, Yuji, Arai, Masaru, Watanabe, Ryuta, Yokoyama, Katsuaki, Matsumoto, Naoya, Nagashima, Koichi, and Okumura, Yasuo

Published
2022
Full Text
View/download PDF

5. Impact of the COVID-19 pandemic on the hospitalizations, time course, presenting symptoms, and mid-term outcomes in patients with myocardial infarctions in a Japanese multi-center registry

Author

Arai, Riku, primary, Nobuhiro, Murata, additional, Kojima, Keisuke, additional, Iida, Korehito, additional, Kitano, Daisuke, additional, Fukamachi, Daisuke, additional, Watanabe, Yoji, additional, Matsumoto, Michiaki, additional, Matsumoto, Naoya, additional, Hirata, Shu, additional, Nomoto, Kazumiki, additional, Sasa, Yusuke, additional, Tachibana, Eizo, additional, Arai, Masaru, additional, Arima, Ken, additional, Haruta, Hironori, additional, and Okumura, Yasuo, additional

Published
2022
Full Text
View/download PDF

7. Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry.

Author

Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, and Okumura Y

Subjects
Aged, Atrial Fibrillation complications, Female, Follow-Up Studies, Humans, Incidence, Japan epidemiology, Male, Middle Aged, Recurrence, Risk Factors, Stroke epidemiology, Stroke etiology, Time Factors, Treatment Outcome, Anticoagulants therapeutic use, Atrial Fibrillation therapy, Catheter Ablation methods, Propensity Score, Registries, Risk Assessment methods, Stroke prevention & control
Abstract

Whether ablation for atrial fibrillation (AF) is, in terms of clinical outcomes, beneficial for Japanese patients has not been clarified. Drawing data from 2 Japanese AF registries (AF Frontier Ablation Registry and SAKURA AF Registry), we compared the incidence of clinically relevant events (CREs), including stroke/transient ischemic attack (TIA), major bleeding, cardiovascular events, and death, between patients who underwent ablation (n = 3451) and those who did not (n = 2930). We also compared propensity-score matched patients (n = 1414 in each group). In propensity-scored patients who underwent ablation and those who did not, mean follow-up times were 27.2 and 35.8 months, respectively. Annualized rates for stroke/TIA (1.04 vs. 1.06%), major bleeding (1.44 vs. 1.20%), cardiovascular events (2.15 vs. 2.49%) were similar (P = 0.96, 0.39, and 0.35, respectively), but annualized death rates were lower in the ablation group than in the non-ablation group (0.75 vs.1.28%, P = 0.028). After multivariate adjustment, the risk of CREs was statistically equivalent between the ablation and non-ablation groups (hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.71-1.11), but it was significantly low among patients who underwent ablation for paroxysmal AF (HR 0.68 [vs. persistent AF], 95% CI 0.49-0.94) and had a CHA 2 DS 2 -VASc score  < 3 (HR 0.66 [vs. CHA 2 DS 2 -VASc score ≥ 3], 95% CI 0.43-0.98]). The 2-year risk reduction achieved by ablation may be small among Japanese patients, but AF ablation may benefit those with paroxysmal AF and a CHA 2 DS 2 -VASc score < 3.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results